You are viewing the site in preview mode

Skip to main content

Table 2 ECG and laboratory findings in the VT and Non-VT group

From: The relationship between J wave and ventricular tachycardia during Takotsubo cardiomyopathy

  Total (n = 79) VT group (n = 20) Non-VT group (n = 59) P value
Electrocardiographic changes
Atrial arrhythmia, n (%) 26 (33) 12 (60) 14 (25) 0.003
AV block, n (%) 2 (2) 0 (0) 2 (3) 1.000
ST-segment elevation, n (%) 36 (45) 9 (45) 27 (45) 1.000
T-wave inversion, n (%) 55 (68) 16 (80) 39 (65) 0.27
Q wave, n (%) 18 (22) 4 (20) 14 (23) 0.51
QTc interval, ms 545.2 ± 63.6 577.0 ± 58.5 534.2 ± 61.1 0.01
Laboratory findings
Sodium, mmol/L 139.1 ± 4.9 139.6 ± 5.9 138.9 ± 4.6 0.59
Potassium, mmol/L 4.1 ± 0.7 3.9 ± 0.8 4.1 ± 0.7 0.64
Ionized calcium, mg/dL 0.96 ± 0.1 0.95 ± 0.1 0.97 ± 0.1 0.51
Magnesium, mg/dL 2.1 ± 0.4 2.1 ± 0.4 2.2 ± 0.4 0.16
Cardiac enzymes
Peak CK, ng/mL 827.2 ± 1409.9 1008.5 ± 1634.4 766.7 ± 1336.7 0.51
Peak CK-MB, ng/mL 30.7 ± 46.9 49.1 ± 69.7 24.7 ± 35.1 0.15
Peak troponin-I, ng/mL 9.8 ± 20.6 16.5 ± 34.1 7.7 ± 13.3 0.28
NT-proBNP, pg/mL 12900.2 ± 13370.2 14179.8 ± 13207.2 12293.6 ± 13499.0 0.28
  1. Values are mean ± SD or number (%); VT ventricular tachycardia; Atrial arrhythmia: PSVT, atrial tachycardia, atrial fibrillation; CK creatine kinase; CK-MB creatine kinase-myocardial band; NT-proBNP N-terminal pro-brain natriuretic peptide
\